HLHui Li

Hui Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hui Li has a total of 120 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Zeng

    Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, China

    8 shared publications
  • Guanghua Lei

    Department of Orthopedics Xiangya Hospital, Central South University Changsha China

    8 shared publications
  • Yilun Wang

    Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China

    8 shared publications
  • Guanghua Lei

    Department of Orthopaedics, Xiangya Hospital, Central South University

    6 shared publications
  • Jie Wei

    Department of Orthopedics Xiangya Hospital, Central South University Changsha China

    6 shared publications
  • Xiaoxiao Li

    Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, China

    6 shared publications

Latest Publications

  • Open Access

    Sustained release of metformin through an injectable hydrogel for synergistic macrophage reprogramming and ROS scavenging in the analgesic treatment of osteoarthritis

    by Jie Xu, Yuhao Chen, Xuan Zhao, Huiyun Li, Honggui Chen, Xiang Ding, Yang Cui, Tingjian Wang, Ning Wang, Caifeng Deng, et al.

    1. Knee osteoarthritis (OA) is a highly prevalent condition, affecting an estimated 600 million people globally as of 2021 (Brauer et al. 2024), and its incidence and prevalence are increasing. Joi...

  • Open Access

    Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases

    by Wenxing Yang, Cong Hao, Ning Wang, Jie Xie, Bin Zhou, Zidan Yang, Aojie Zheng, Jie Wei, Changjun Li, Cen Xie, et al.

    Degenerative musculoskeletal diseases are characterized by the progressive loss of structural integrity and functional capacity in muscles, bones, joints, and other related tissues. These conditions primarily include osteoarthritis, osteoporosis, sarcopenia, and intervertebral disc degeneration. These diseases progress gradually, leading to chronic pain, impaired mobility, and a significantly elevated risk of disability. Given their high prevalence and substantial health burden, degenerative musculoskeletal diseases pose a major challenge in the context of population aging. Although various types of degenerative musculoskeletal diseases affect different primary tissues, they share common pathological features including chronic inflammation, oxidative stress, and dysregulated cell death. These shared mechanisms imply the existence of a common molecular regulatory network. Glucagon-like peptide-1 (GLP-1), a peptide secreted under the regulation of the gut microbiota (GM), has garnered increasing attention for its protective roles in bone, cartilage, muscle, and intervertebral disc tissues. GLP-1 reduces inflammation, mitigates oxidative stress, inhibits apoptosis, and supports microbial homeostasis. This review outlines the mechanisms through which the GM regulates GLP-1 secretion. It further summarizes the core functions and disease-specific pathways by which GLP-1 confers protection against degenerative musculoskeletal diseases. Finally, it explores potential therapeutic strategies targeting the "GM-GLP-1" axis, highlighting microbiota modulation and GLP-1 pathway enhancement as promising treatment approaches for degenerative musculoskeletal diseases.


  • Top Cited Papers

    Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling

    by Yuanheng Yang, Cong Hao, Tingying Jiao, Zidan Yang, Hui Li, Yuqing Zhang, Weiya Zhang, Michael Doherty, Chuying Sun, Tuo Yang, et al.

    Whether a gut-joint axis exists to regulate osteoarthritis is unknown. In two independent cohorts, we identified altered microbial bile acid metabolism with reduced glycoursodeoxycholic acid (GUDCA) in osteoarthritis. Suppressing farnesoid X receptor (FXR)—the receptor of GUDCA—alleviated osteoarthritis through intestine-secreted glucagon-like peptide 1 (GLP-1) in mice. GLP-1 receptor blockade attenuated these effects, whereas GLP-1 receptor activation mitigated osteoarthritis. Osteoarthritis patients exhibited a lower relative abundance of Clostridium bolteae , which promoted the formation of ursodeoxycholic acid (UDCA), a precursor of GUDCA. Treatment with C. bolteae and Food and Drug Administration–approved UDCA alleviated osteoarthritis through the gut FXR–joint GLP-1 axis in mice. UDCA use was associated with lower risk of osteoarthritis-related joint replacement in humans. These findings suggest that orchestrating the gut microbiota–GUDCA–intestinal FXR–GLP-1–joint pathway offers a potential strategy for osteoarthritis treatment.


  • Cohort Profile: The Xiangya Osteoarthritis (XO) Study

    by Jiatian Li, Tuo Yang, Yuqing Zhang, Weiya Zhang, Michael Doherty, Junqing Xie, Yilun Wang, Ting Jiang, Dongxing Xie, Hui Li, et al.

    Osteoarthritis (OA), the most common joint disorder worldwide, is associated with pain, stiffness, reduced mobility and impaired quality of life, significantly contributing to disability and socioeconomic burden. 1 The prevalence and incidence of OA vary significantly between developed and developing countries. 2 Despite being one of the most populated developing countries, few longitudinal OA studies exist in China, and these have focused solely on the tibiofemoral joint. This results in an information gap regarding the overall burden of OA at different joint sites, its temporal trends, natural history, outcomes and the mechanisms involved in its onset and progression. Identifying the risk factors for OA is crucial for understanding its mechanisms and developing prevention strategies. Community-based cohort studies that follow participants over an extended period have particular advantages for uncovering disease risk factors. 3 OA research has benefited significantly from several community-based cohort studies in other countries. 4–8 Although traditional risk factors for radiographic tibiofemoral OA, such as older age, female gender, obesity and joint injuries, have been confirmed, 1 most of them are not modifiable. Therefore, there is an urgent need to find novel, modifiable risk factors for OA at multiple joints.


  • Dysbiosis of gut microbiota, a potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-based study

    by Ting Jiang, Zidan Yang, Yuqing Zhang, Weiya Zhang, Michael Doherty, Hui Li, Tuo Yang, Yuanheng Yang, Jiatian Li, Yuqing Wang, et al.

    Hand synovitis, a potentially modifiable pathological lesion, is common and associated with pain and hand osteoarthritis; nevertheless, its pathogenesis remains uncertain. This study investigated the relationship between gut microbiota dysbiosis and hand synovitis prevalence and evaluated whether bile acids mediate the association. Participants were derived from a community-based observational study. Synovitis in each hand joint was assessed using ultrasound. Gut microbiota was evaluated using 16S ribosomal RNA amplicon sequencing on feces, and plasma bile acids were measured by high-performance liquid chromatography mass spectrometry. We examined the relationship between gut microbiota dysbiosis and hand synovitis prevalence, as well as the extent to which bile acids were involved in the association. Among 1,336 participants (mean age: 63.2 years; women: 58.8%), 18.3% had prevalent hand synovitis (unilateral in 13.6% and bilateral in 4.7%). β-diversity, but not α-diversity, of gut microbiota was significantly associated with prevalent hand synovitis. The higher relative abundance of genus Prevotella and the lower relative abundance of genus Blautia were significantly associated with the prevalence of hand synovitis. Similar associations were also observed for laterality and the number of joints affected by hand synovitis. The association between Prevotella and hand synovitis was partially mediated through its effect on tauroursodeoxycholic acid and glycoursodeoxycholic acid, the mediation proportions being 25.7% and 21.6%, respectively. Our findings suggest that gut microbiota dysbiosis is associated with the prevalence of hand synovitis. Such an association appears to be partially mediated by plasma bile acids.


  • Open Access

    Pain Intensity and Trajectory Following Intra-Articular Injection of Mono-Iodoacetate in Experimental Osteoarthritis: A Meta-Analysis of In Vivo Studies

    by Hongyu Jin, Yuanheng Yang, Guanghua Lei, Chao Zeng, Ke He, Yilun Wang, Caifeng Deng, Jie Wei, Xiaoxiao Li, Hui Li

    Objective: Although most frequently used in experimental osteoarthritis (OA) pain induction, intra-articular mono-iodoacetate (MIA) injection lacks concluded references for dose selection and timing of intervention. Herein, we aimed to compare the pain intensity of rats induced by different doses of MIA and explored the trajectory of pain. Design: PubMed, Embase, and Web of Science were searched up to June 2021 for literatures involving MIA experiments investigating OA pain. Pain intensity was measured based on weightbearing distribution (WBD) and paw withdrawal thresholds (PWT), and the pain trajectory was constructed by evaluating pain intensity at a series of time points after MIA injection. A conventional meta-analysis was conducted. Results: A total of 140 studies were included. Compared with saline, MIA injections caused significantly higher pain intensity for WBD and PWT. Dose-response relationships between different doses of MIA and pain intensity were observed ( P-for-trend<0.05). A pronounced increase in pain occurred from day 0 to day 7, but the uptrend ceased between day 7 and day 14, after which the pain intensity continued to rise and reached the maximum by day 28. Conclusions: Pain intensity after intra-articular MIA injection increased in a dose-dependent manner and the pain trajectory manifested a specific pattern consistent with the pathological mechanisms of MIA-induced pain, providing possible clues for proper dose selection and timing of specific OA pain interventions.


  • Anteromedial Portal Technique, but Not Outside‐in Technique, Is Superior to Standard Transtibial Technique in Knee Stability and Functional Recovery After Anterior Cruciate Ligament Reconstruction: A Network Meta‐analysis

    by Haoran Feng, Ning Wang, Dongxing Xie, Zidan Yang, Chao Zeng, Guanghua Lei, Hui Li, Yilun Wang

    Purpose: To compare the postoperative outcomes of 4 different femoral drilling techniques in anterior cruciate ligament reconstruction. Methods: Three databases were searched for randomized controlled trials comparing any 2 or more of the following femoral drilling techniques in anterior cruciate ligament reconstruction: standard transtibial (sTT), anteromedial portal (AMP), outside‐in (OI), or modified transtibial (mTT) technique. A Bayesian network meta‐analysis was performed to assess postoperative stability and functional recovery in terms of the side‐to‐side difference (measured by arthrometry), Lachman test, pivot‐shift test, International Knee Documentation Committee subjective and objective scores, Lysholm score, and Tegner score. The Fisher exact probability test and χ 2 test were used to compare the incidences of infection and graft rupture, respectively. Results: We included 20 randomized controlled trials involving 1,515 patients. The AMP technique showed a lower side‐to‐side difference (standardized mean difference, –0.33; 95% credible interval [CrI], –0.53 to –0.12), higher negative rate on the pivot‐shift test (odds ratio, 2.19; 95% CrI, 1.38 to 3.44), and higher International Knee Documentation Committee objective score (odds ratio, 3.13; 95% CrI, 1.42 to 7.82) than the sTT technique. However, knee stability and functional outcomes did not differ significantly between the OI and sTT techniques. Safety outcomes of the mTT technique were unavailable. The incidence of graft rupture was 5.20% for the OI technique, 2.27% for the AMP technique, and 1.51% for the sTT technique. The OI technique had a significantly higher incidence of graft rupture than the sTT technique (χ 2 = 4.421, P = .035). No significant difference in the incidence of infection was found between the sTT, AMP, and OI techniques ( P = .281). Conclusions: The AMP technique, but not the OI technique, was superior to the sTT technique in knee stability and functional recovery. The OI technique had a higher incidence of graft rupture than the sTT technique. There was no significant difference between the AMP and OI techniques or between the mTT technique and any other femoral drilling technique. Level of Evidence: Level II, meta‐analysis of Level I and II studies.


  • Anterior cruciate ligament tear increases the risk of venous thromboembolism: a population‐based cohort study

    by Yilin Xiong, Xiaoxiao Li, Guanghua Lei, Chao Zeng, Jie Wei, Xiang Ding, Hui Li

    Purpose: Previous studies highlighted an increased risk of venous thromboembolism (VTE) among patients with anterior cruciate ligament reconstruction (ACLR); however, the risk for those with ACL tear but without undergoing ACLR has not been reported yet. The aim of this study was to evaluate the risk of VTE among ACL tear individuals with or without ACLR derived from the general population.Methods: A cohort study was conducted using data from the IQVIA Medical Research Database of the United Kingdom. Up to five non‐ACL tear individuals (n = 22,235) were matched to each case of ACL tear (n = 4474) by age, sex, body mass index and entry‐time. The relation of ACL tear to VTE [pulmonary embolism (PE) and deep vein thrombosis (DVT)] was examined using a multivariable Cox proportional hazard model. A sub‐cohort analysis, in which the ACL tear individuals were stratified into those with ACLR and those without ACLR, was also conducted.Results: VTE developed in 13 individuals with ACL tear and nine individuals without ACL tear (incidence rates: 3.1 vs. 0.4/1000 person‐years), with multivariable‐adjusted hazard ratio (HR) being 6.59 (95% CI 2.28–19.08) in 1‐year follow‐up. For ACL tear individuals with ACLR, the HR was 11.44 (95% CI 2.71–48.28), and for those without ACLR, the HR was 6.02 (95% CI 1.44–24.25), compared with individuals without ACL tear.Conclusion: This large‐sample population‐based cohort study provides the first evidence on an increased risk of VTE in ACL tear individuals regardless of subsequent ACLR, which supports the necessity for monitoring venous‐thromboembolic complications in the target population, including those without ACLR.Level of evidence: III.


  • Open Access

    Association between sarcopenia and osteoarthritis: A protocol for meta-analysis

    by Haochen Wang, Ning Wang, Yilun Wang, Hui Li

    Background: Sarcopenia, a relatively new syndrome referring to the age-related decline of muscle strength and degenerative loss of skeletal muscle mass and function, often resulting in frailty, disability, and mortality. Osteoarthritis, as a prevalent joint degenerative disease, is affecting over 250 million patients worldwide, and it is the fifth leading cause of disability. Despite the high prevalence of osteoarthritis, there are still lack of efficient treatment potions in clinics, partially due to the heterogeneous and complexity of osteoarthritis pathology. Previous studies revealed the association between sarcopenia and osteoarthritis, but the conclusions remain controversial and the prevalence of sarcopenia within osteoarthritis patients still needs to be elucidated. To identify the current evidence on the prevalence of sarcopenia and its association with osteoarthritis across studies, we performed this systematic review and meta-analysis that would help us to further confirm the association between these two diseases. Methods and analysis: Electronic sources including PubMed, Embase, and Web of Science will be searched systematically following appropriate strategies to identify relevant studies from inception up to 28 February 2022 with no language restriction. Two investigators will evaluate the preselected studies independently for inclusion, data extraction and quality assessment using a standardized protocol. Meta-analysis will be performed to pool the estimated effect using studies assessing an association between sarcopenia and osteoarthritis. Subgroup analyses will also be performed when data are sufficient. Heterogeneity and publication bias of included studies will be investigated. PROSPERO registration number: CRD42020155694.